Recurrence of papillary thyroid cancer suspected by high anti-thyroglobulin antibody levels and detection of peripheral blood thyroglobulin mRNA

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1321-1325

  Coelho, Sabrina Mendes ^a   Buescu, Alexandru ^a   Corbo, Rossana ^a   Carvalho, Denise P ^a   Vaisman, Mário ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Leblon ^*  (Brazil)

Author keywords

Anti TG antibody; Relapse; Thyroglobulin; Thyroglobulin mRNA; Thyroid cancer

Indexed keywords

EID: 58849099087     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000800019     Document Type: Article

References (21)

1. Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocrine-Related Cancer. 2002;9:227-47.
2. Maia AL, Ward LS, Carvalho GA, Graf H, Maciel RM, Maciel LM, et al. Thyroid nodules and differentiated thyroid cancer: Brazilian consensus. Arq Bras Endocrinol Metab. 2007;51:867-93.
3. Schlumberger M, Pacini F. Thyroid tumors. Éditions Nucléon, Paris. 1999.
4. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1998;83:1121-7.
5. Ringel MD, Ladenson PW, Levine MA. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab. 1998;83:4435-42.
6. Schlumberger M, Tubiana M, Vathaire F, Hill C, Gardet P, Travagli J-P, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986;63:960-7.
7. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37:598-605.
8. Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002; 87:3242-7.
9. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433-41.
10. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139(5 Pt 1):346-51.
11. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Lo Gerfo P. Detection of circulating thyroid cells in peripheral blood. Surgery. 1996;120:959-65.
12. Gupta MK, Taguba L, Areiaga R, Siperstein A, Faiman C, Mehta A, Reddy SSK. Detection of circulating thyroid cancer cells by reverse transcription-PCR for thyroid stimulating hormone receptor and thyroglobulin: the importance of primer selection. Clin Chem. 2002;48:1862-5.
13. Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE, et al. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J Clinl Endocrinol Metab 2004;89:3705-9.
14. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, et al. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type. Cancer. 2001;92:2273-9.
15. Tallini G, Ghossein RA, Emanuel J, Gill J, Kinder B, Dimich AB, et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998;16:1158-66.
16. Elisei R, Vivaldi A, Agate L, Molinaro E, Nencetti C, Grasso L, et al Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab. 2004;89: 33-9.
17. Biscolla RP, Cerutti JM, Maciel RM. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab. 2000;85:3623-7.
18. Bugalho MJ, Domingues RS, Pinto AC, Garrão A, Catarino AL, Ferreira T, et al. Detection of thyroglobulin mRNA transcripts in peripheral blood individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol. 2001;145:409-13.
19. Francis T, Burch HB, Cai W, Lukes Y, Peele M, Carr FE, et al. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid. 1991;1:223-8.
20. Karavitaki N, Lembessis P, Tzanela M, Vlassopoulou V, Thalassinos N, Koutsilieris M. Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy. Anticancer Res. 2005;25(4):3135-42.
21. Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma k, Amino N. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer. 2001;85:102-6.